Works about OMALIZUMAB

Results: 459
    1
    2

    Omalizumab in pediatric chronic spontaneous urticaria: A systematic review and meta‐analysis of efficacy and safety.

    Published in:
    Pediatric Allergy & Immunology, 2025, v. 36, n. 6, p. 1, doi. 10.1111/pai.70132
    By:
    • Alomari, Omar;
    • Ozceker, Deniz;
    • Mokresh, Muhammed Edib;
    • Topçak, Asli Berivan;
    • Ertan, Sinem Nur;
    • Şahin, Merve Karaca;
    • Çalışkan, Nilay;
    • Karadag, Sefika Ilknur Kökcü;
    • Erbay, Muhammed Fatih;
    • Yıldırım, Güler;
    • Bologur, Hamit;
    • Güngör, Hilal;
    • Kaplan, Ozlem;
    • Tunç, Hasan Sarman;
    • Göncü, Emek Kocatürk
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Bioequivalence Between a New Omalizumab Prefilled Syringe With an Autoinjector or with a Needle Safety Device Compared with the Current Prefilled Syringe: A Randomized Controlled Trial in Healthy Volunteers.

    Published in:
    Clinical Pharmacology in Drug Development, 2024, v. 13, n. 6, p. 611, doi. 10.1002/cpdd.1373
    By:
    • Sangana, Ramachandra;
    • Xu, Yan;
    • Shah, Bharti;
    • Tian, Xianbin;
    • Zack, Julia;
    • Shakeri‐Nejad, Kasra;
    • Kalluri, Sampath;
    • Jones, Ieuan;
    • Ligueros‐Saylan, Monica;
    • Taylor, Angel Fowler;
    • Jain, Devendra Kumar;
    • Scosyrev, Emil;
    • Uddin, Alkaz;
    • Laurent, Nathalie;
    • Paganoni, Paola
    Publication type:
    Article
    19
    20
    21

    Biological treatment for bullous pemphigoid.

    Published in:
    Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1157250
    By:
    • Oren-Shabtai, Meital;
    • Mimouni, Daniel;
    • Nosrati, Adi;
    • Atzmony, Lihi;
    • Kaplan, Baruch;
    • Barzilai, Aviv;
    • Baum, Sharon
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Efficacy and safety of CT‐P39, an omalizumab biosimilar, in chronic spontaneous urticaria: 16‐week follow‐up study.

    Published in:
    Clinical & Translational Allergy, 2025, v. 15, n. 6, p. 1, doi. 10.1002/clt2.70069
    By:
    • Grattan, Clive;
    • Dytyatkovska, Yevgeniya;
    • Springer, Michał;
    • Ratkova, Maria;
    • Krusheva, Borislava;
    • Krupa‐Borek, Izabella;
    • Pulka, Grazyna;
    • Chełmińska, Marta;
    • Reich, Adam;
    • Kim, Sunghyun;
    • Bae, Yunju;
    • Kim, Suyoung;
    • Lee, Sewon;
    • An, Eunjin;
    • Park, Jeong Eun;
    • Ka, Jieun;
    • Kim, Jongho;
    • Saini, Sarbjit S.
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44

    Clinical characteristics of complete responders versus non-complete responders to omalizumab, benralizumab and mepolizumab in patients with severe asthma: a long-term retrospective analysis.

    Published in:
    Annals of Medicine, 2024, v. 56, n. 1, p. 1, doi. 10.1080/07853890.2024.2317356
    By:
    • Basagaña, Maria;
    • Martínez-Rivera, Carlos;
    • Padró, Clara;
    • Garcia-Olivé, Ignasi;
    • Martínez-Colls, Mimar;
    • Navarro, Juan;
    • Pardo, Laura;
    • Cruz, Paula;
    • Cardona Peitx, Gloria;
    • Carabias, Lídia;
    • Roger, Albert;
    • Abad, Jorge;
    • Rosell, Antoni
    Publication type:
    Article
    45
    46
    47

    Cholinergic pruritus treated with omalizumab: Seven cases.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 11, p. e933, doi. 10.1111/jdv.19997
    By:
    • Bréhon, Alice;
    • Hamelin, Aurore;
    • Cariou, Claire;
    • Senet, Patricia;
    • Sonigo, Gabrielle;
    • De Risi, Tullia;
    • Barbaud, Annick;
    • Amsler, Emmanuelle;
    • Soria, Angèle
    Publication type:
    Article
    48
    49
    50